In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy.
The effects of Photofrin-mediated photodynamic therapy (PDT) on the in vitro cell survival and in vivo tumor growth of murine radiation-induced fibrosarcoma (RIF) cell tumors have been examined following in vivo PDT treatment of tumors. The response to in vivo PDT is examined in tumors derived from RIF-1 mouse fibrosarcoma cells and in tumors derived from RIF-8A cells, which show in vitro resistance to PDT. A significant reduction in tumor volume is observed over the first three days following in vivo PDT treatment of either 5 or 10 mg/ kg. The reduction in tumor volume is greater for a 10 compared to a 5 mg/ml dose and occurs to a similar extent for both RIF-1 and RIF-8A tumors. The re-growth is significantly delayed for RIF-1 compared to RIF-8A tumors, indicating a greater response for RIF-1 tumors compared to RIF-8A tumors following PDT. A reduced response of the RIF-8A compared to the RIF-1 tumor cells is also observed in the clonogenic survival of cells from tumors that were excised and explanted in vitro immediately following in vivo PDT treatment. These data indicate that the intrinsic cell sensitivity to PDT is an important component in the mechanism that leads to tumor response following in vivo photodynamic therapy.
Adams
K
K
Hamilton Regional Cancer Centre, Ontario, Canada.
Rainbow
A J
AJ
Wilson
B C
BC
Singh
G
G
D000818:Animals; D002470:Cell Survival; D017323:Dihematoporphyrin Ether / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D005354:Fibrosarcoma / Q000098:blood supply / Q000188:drug therapy*; D051379:Mice; D009381:Neoplasms, Radiation-Induced / Q000098:blood supply / Q000188:drug therapy*; D010778:Photochemotherapy; D014407:Tumor Cells, Cultured
D017323:Dihematoporphyrin Ether